Chapter 7. Multiple Sclerosis Therapeutic Market: Regional Estimates & Trend Analysis
7.1. Multiple Sclerosis Therapeutic Market Share, By Region, 2024 & 2030 (USD Million)
7.2. North America
7.2.1. North America Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Multiple Sclerosis Therapeutic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 4 Global Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 5 Global Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 6 North America Multiple Sclerosis Therapeutics Market, By Country, 2018 - 2030 (USD Million)
Table 7 North America Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 8 North America Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 9 North America Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 10 U.S Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 11 U.S Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 12 U.S Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 13 Canada Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 14 Canada Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 15 Canada Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Mexico Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 17 Mexico Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 18 Mexico Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 19 Europe Multiple Sclerosis Therapeutics Market, By Country, 2018 - 2030 (USD Million)
Table 20 Europe Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 21 Europe Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 22 Europe Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 23 UK Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 24 UK Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 25 UK Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 26 Germany Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 27 Germany Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million))
Table 28 Germany Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 29 France Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 30 France Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 31 France Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Italy Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 33 Italy Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 34 Italy Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 35 Spain Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 36 Spain Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 37 Spain Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 38 Denmark Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 39 Denmark Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 40 Denmark Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 41 Sweden Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 42 Sweden Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 43 Sweden Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Norway Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 45 Norway Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 46 Norway Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Multiple Sclerosis Therapeutics Market, By Country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 51 Japan Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 52 Japan Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 53 Japan Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 54 China Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 55 China Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 56 China Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 57 India Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 58 India Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 59 India Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 60 South Korea Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 61 South Korea Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 62 South Korea Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 63 Australia Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 64 Australia Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 65 Australia Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 66 Thailand Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 67 Thailand Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 68 Thailand Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 69 Latin America Multiple Sclerosis Therapeutics Market, By Country, 2018 - 2030 (USD Million)
Table 70 Latin America Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 71 Latin America Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 72 Latin America Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 73 Brazil Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 74 Brazil Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 75 Brazil Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Argentina Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 77 Argentina Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 78 Argentina Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Multiple Sclerosis Therapeutics Market, By Country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 83 South Africa Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 84 South Africa Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 85 South Africa Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 86 UAE Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 87 UAE Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 88 UAE Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 89 Kuwait Multiple Sclerosis Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 90 Kuwait Multiple Sclerosis Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 Kuwait Multiple Sclerosis Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Multiple Sclerosis Therapeutics Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Multiple Sclerosis Therapeutics market: Drug Class outlook and key takeaways
Fig. 15 Multiple Sclerosis Therapeutics market: Drug Class movement analysis & market share 2024 & 2030
Fig. 16 Immunosuppressants market, 2018 - 2030 (USD Million)
Fig. 17 Immunostimulants market, 2018 - 2030 (USD Million)
Fig. 18 Multiple Sclerosis Therapeutics market: Route of Administration outlook and key takeaways
Fig. 19 Multiple Sclerosis Therapeutics market: Route of Administration movement analysis & market share 2024 & 2030
Fig. 20 Oral Multiple Sclerosis Therapeutics market, 2018 - 2030 (USD Million)
Fig. 21 Injectable Multiple Sclerosis Therapeutics market, 2018 - 2030 (USD Million)
Fig. 22 Others Multiple Sclerosis Therapeutics market, 2018 - 2030 (USD Million)
Fig. 23 Multiple Sclerosis Therapeutics market: Distribution Channel outlook and key takeaways
Fig. 24 Multiple Sclerosis Therapeutics market: Distribution Channel movement analysis & market share 2024 & 2030
Fig. 25 Hospital Pharmacies, 2018 - 2030 (USD Million)
Fig. 26 Retail Pharmacies, 2018 - 2030 (USD Million)
Fig. 27 E-Commerce, 2018 - 2030 (USD Million)
Fig. 28 Regional Marketplace: Key Takeaways
Fig. 29 Regional Outlook, 2024 & 2030
Fig. 30 Regional Market Dashboard
Fig. 31 Regional Market Place: Key Takeaways
Fig. 32 North America
Fig. 33 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 34 U.S. Key Country Dynamics
Fig. 35 U.S. Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 36 Canada Key Country Dynamics
Fig. 37 Canada Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 38 Mexico Key Country Dynamics
Fig. 39 Mexico Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 40 Europe
Fig. 41 Europe Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 42 UK Key Country Dynamics
Fig. 43 UK Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 44 Germany Key Country Dynamics
Fig. 45 Germany Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 46 France Key Country Dynamics
Fig. 47 France Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 48 Italy Key Country Dynamics
Fig. 49 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 50 Spain Key Country Dynamics
Fig. 51 Spain Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 52 Denmark Key Country Dynamics
Fig. 53 Denmark Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 54 Sweden Key Country Dynamics
Fig. 55 Sweden Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 56 Norway Key Country Dynamics
Fig. 57 Norway Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 58 Asia Pacific
Fig. 59 Asia-Pacific Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 60 Japan Key Country Dynamics
Fig. 61 Japan Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 62 China Key Country Dynamics
Fig. 63 China Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 64 India Key Country Dynamics
Fig. 65 India Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 66 Australia Key Country Dynamics
Fig. 67 Australia Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 68 Thailand Key Country Dynamics
Fig. 69 Thailand Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 70 South Korea Key Country Dynamics
Fig. 71 South Korea Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 72 Latin America
Fig. 73 Latin America Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 74 Brazil Key Country Dynamics
Fig. 75 Brazil Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 76 Argentina Key Country Dynamics
Fig. 77 Argentina Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 78 MEA
Fig. 79 MEA Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 80 South Africa Key Country Dynamics
Fig. 81 South Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 82 Saudi Arabia Key Country Dynamics
Fig. 83 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 84 UAE Key Country Dynamics
Fig. 85 UAE Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 86 Kuwait Key Country Dynamics
Fig. 87 Kuwait Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 88 Strategy Mapping